FDA Clears AIRS Medical’s AI MRI Tool for Body Composition Analysis

AIRS Medical said on October 5, 2026, that the U.S. Food and Drug Administration granted 510(k) clearance for SwiftSight Body Composition, its AI-powered quantitative MRI software, with SimonMed Imaging as the first customer to deploy it. The Chicago-datelined announcement said the clearance expands the company's quantitative MRI platform into body composition analysis. SwiftSight Body Composition uses AI-powered MRI analysis to quantify muscle and adipose tissue from MR images. According to…

This article has been indexed from Unite.AI

Read the original article: